CV. Production of equine sera as a potential immunotherapy against COVID-19
Mariana V. Cepeda, et al. Invest Clin 62(Suppl. 2): 3 – 17, 2021 https://doi.org/10.22209/IC.v62s2a01 Recopilado por Carlos Cabrera Lozada. Director del postgrado de Medicina Materno Fetal. Universidad Central de Venezuela. ORCID: 0000-0002-3133-5183. 22/08/2021 Abstract Emerging viruses such as the COVID-19-inducing virus, SARS-CoV-2, represent a threat to human health, unless effective vaccines, drugs or alternative treatments, such as
CV. Production of equine sera as a potential immunotherapy against COVID-19 Leer más »
